SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-21-022528
Filing Date
2021-04-30
Accepted
2021-04-30 16:07:06
Documents
12
Effectiveness Date
2021-04-30

Document Format Files

Seq Description Document Type Size
1 S-8 orph-s8.htm S-8 113159
2 EX-4.1 orph-ex41_28.htm EX-4.1 132186
3 EX-5.1 orph-ex51_7.htm EX-5.1 71782
4 EX-10.1 orph-ex101_8.htm EX-10.1 177640
5 EX-10.2 orph-ex102_9.htm EX-10.2 110943
6 EX-23.1 orph-ex231_6.htm EX-23.1 2527
7 GRAPHIC gthsifndpzj5000002.jpg GRAPHIC 26378
8 GRAPHIC gthsifndpzj5000001.jpg GRAPHIC 19712
9 GRAPHIC gthsifndpzj5000003.jpg GRAPHIC 19709
10 GRAPHIC gthsifndpzj5000004.jpg GRAPHIC 27170
11 GRAPHIC g3qymfkd1xnw000002.jpg GRAPHIC 1879
12 GRAPHIC g3qymfkd1xnw000001.jpg GRAPHIC 1252
  Complete submission text file 0001564590-21-022528.txt   742511
Mailing Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200
Business Address OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200 45 39 17 82 72
Orphazyme A/S (Filer) CIK: 0001764791 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-255661 | Film No.: 21877899
SIC: 2834 Pharmaceutical Preparations